Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05658263 · ClinicalTrials.gov registry record · Early Phase 1
Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet
A Early Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 14
- Enrollment target
NCT05658263 is a Early Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 14 participants.
The verdict
NCT05658263, a Early Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
The long-term study objective is to develop optimized nutritional therapies for surgery and test them in clinical practice. This pilot study will test a microbiome-optimization diet in colorectal cancer surgery patients. The study hypothesizes that the Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet will provide participants with increased microbiota accessible carbohydrates (MACs) to support the microbiome and improve outcomes.
Interventions
- DIETARY_SUPPLEMENT Standard Diet
- DIETARY_SUPPLEMENT BIG MACS Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2023-01-03 |
| Est. Completion | 2024-08-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05658263
The ClinicalTrials.gov registry entry for NCT05658263 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Diet is the first listed.
NCT05658263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05658263 about?
NCT05658263 is a clinical study titled "Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet". The long-term study objective is to develop optimized nutritional therapies for surgery and test them in clinical practice. This pilot study will test a microbiome-optimization diet in colorectal cancer surgery patients. The study hypothesizes that the Bacterial Intestinal Gut Modification Around Ca...
What is the current status of trial NCT05658263?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 14 participants. The study started on 2023-01-03. Estimated completion is 2024-08-15.
What interventions are being tested in trial NCT05658263?
The interventions under investigation include: Standard Diet (DIETARY_SUPPLEMENT), BIG MACS Diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05658263?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.